Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Novartis presents new VEGF inhibitors for cancer and ocular disorders

July 29, 2004

Merck researchers claim new tyrosine kinase regulators and their use

July 29, 2004

Promising antitumor activity reported for DRF-1042 in patients with refractory solid tumors

July 28, 2004

PBI-1402: a hematopoietic growth stimulant and chemoprotective agent

July 28, 2004

Korean team describes antitumor agents targeting Wnt-signaling pathways

July 28, 2004

Novel protein kinase inhibitors and their use in cancer therapy

July 27, 2004

DMAG enters phase I

July 26, 2004

Access updates progress of AP-5346

July 26, 2004

FDA to grant additional six months pediatric exclusivity to clofarabine

July 26, 2004

Celera Genomics and Seattle Genetics to develop antibody therapies for cancer

July 26, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...